Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Gregory M ChenKai Tan

Abstract

The adoptive transfer of genetically engineered chimeric antigen receptor (CAR) T cells has opened a new frontier in cancer therapy. Unlike the paradigm of targeted therapies, the efficacy of CAR T-cell therapy depends not only on the choice of target but also on a complex interplay of tumor, immune, and stromal cell communication. This presents both challenges and opportunities from a discovery standpoint. Whereas cancer consortia have traditionally focused on the genomic, transcriptomic, epigenomic, and proteomic landscape of cancer cells, there is an increasing need to expand studies to analyze the interactions between tumor, immune, and stromal cell populations in their relevant anatomical and functional compartments. Here, we focus on the promising application of systems biology to address key challenges in CAR T-cell therapy, from understanding the mechanisms of therapeutic resistance in hematologic and solid tumors to addressing important clinical challenges in biomarker discovery and therapeutic toxicity. We propose a systems biology view of key clinical objectives in CAR T-cell therapy and suggest a path forward for a biomedical discovery process that leverages modern technological approaches in systems biology.

References

Nov 10, 2001·Annual Review of Genomics and Human Genetics·T IdekerL Hood
Nov 15, 2002·Nature·Hiroaki Kitano
Jun 5, 2007·Journal of Theoretical Biology·F Castiglione, B Piccoli
Mar 19, 2009·Cancer Research·Helena HarlinThomas F Gajewski
May 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bradley C CarthonPadmanee Sharma
Aug 10, 2010·Nature Medicine·Liang-Ping LiThomas Blankenstein
Mar 19, 2011·Cell·Marc VidalAlbert-László Barabási
May 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
May 4, 2012·Science Translational Medicine·John SchollerCarl H June
Jul 12, 2012·Nature Biotechnology·Bissan Al-LazikaniPaul Workman
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
May 2, 2013·Trends in Immunology·Tal Shay, Joonsoo Kang
May 30, 2013·Nature Genetics·UNKNOWN GTEx Consortium
Sep 21, 2013·Nature Reviews. Genetics·Koyel MitraTrey Ideker
Sep 21, 2013·Nature Immunology·Thomas F GajewskiYang-Xin Fu
Sep 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sjoukje J C van der StegenJohn Maher
Oct 22, 2013·Nature Biotechnology·Christian S Hinrichs, Nicholas P Restifo
Mar 4, 2014·Nature Medicine·Michael AngeloGarry P Nolan
Mar 4, 2014·Nature Methods·Charlotte GiesenBernd Bodenmiller
Jul 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Pappanaicken R KumaresanLaurence J N Cooper
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Jan 30, 2015·Nature Reviews. Genetics·Oliver StegleJohn C Marioni
Mar 11, 2015·Nature·Christina Twyman-Saint VictorAndy J Minn
Apr 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Emanuela RomanoDaniel E Speiser
Jun 20, 2015·Trends in Biotechnology·Deboki Chakravarti, Wilson W Wong
Aug 1, 2015·Nature Reviews. Drug Discovery·Kathleen M MahoneyGordon J Freeman
Sep 12, 2015·Science·Eliezer M Van AllenLevi A Garraway
Dec 19, 2015·Cancer Cell·Lorenzo GalluzziGuido Kroemer
Jan 8, 2016·Science Translational Medicine·Nathan SinghDavid M Barrett
Feb 14, 2016·Immunity·Christina PfirschkeMikael J Pittet
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin WeideJedd D Wolchok
Jul 28, 2016·The Journal of Clinical Investigation·Leonid CherkasskyPrasad S Adusumilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Stefan KiesgenPrasad S Adusumilli
© 2021 Meta ULC. All rights reserved